MESALAMINE 800 mg Tablet, Delayed Release
Coverage in South Carolina (CMS PDP Region 09).
1 of 11 stand-alone Part D plans in South Carolina cover this drug on tier 4.
No plan applies a prior authorization, step therapy or quantity limit.
Every plan that covers it
See Mesalamine on one plan, with the monthly patient cost →
Showing 1 of 1 plan
| Plan | Tier | 30-day preferred | 90-day mail | Unit cost | Est. 30-day fill | Restrictions |
|---|---|---|---|---|---|---|
| HealthSpring Extra Rx (PDP)$71.20/mo premium · $615.00 deductible | 4Non-Preferred Drug | 30% | 30% | $3.5780 | — | None |
Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.
What it costs through the year
- Negotiated price per unit
- $3.58
- across 1 plan; median $3.58
- 1. Deductible. Until you have met your plan’s deductible ($615.00 on the plans covering it), you pay the plan’s full negotiated price. Some plans exempt lower tiers from the deductible; the plan page says which.
- 2. Initial coverage. You pay the plan’s copay or coinsurance: 30% of the negotiated price.
- 3. Catastrophic coverage. Once your out-of-pocket spending for the year reaches $2,100.00, you pay $0 for covered drugs for the rest of 2026.
Work out your 2026 costs month by month in the PDP-Planner →
Prices are each plan’s negotiated price from the CMS 2026 prescription drug plan pricing file, which a pharmacy may differ from slightly. On every plan, a covered insulin costs no more than $35 a month and the deductible does not apply to it.
Medicare Advantage plans
Medicare Advantage plans carry their own formularies, separate from stand-alone Part D, and are sold county by county. Pick a county to see every Medicare Advantage drug plan there that covers this drug.
21 Medicare Advantage plans in SC do cover it
A patient on an MA-PD plan may have coverage even where no PDP lists the drug. SC: 21 plans.